Avience Biomedicals Ltd vs Earkart Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of Earkart Limited is 0 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Earkart Limited is ₹ 0 crore as of March 2024 . The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Earkart Limited changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Earkart Limited

Earkart Limited was originally formed as a Private Limited Company in the name and style of 'Earkart Private Limited' on April 14, 2021 vide Certificate of Incorporation issued by Registrar of Companies, Kanpur.
On October 11, 2021, Rohit Misra acquired a majority of the equity shares from them and became the Promoter of the Company.
Thereafter, the status of the Company was taken public and the name was changed to 'Earkart Limited' dated December 18, 2024 by the Registrar of Companies, Central Processing Centre. Company manufacture and distribute modern hearing aids and related accessories at affordable price across India.
Along with the own manufactured hearing aid, it also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.
In addition, it offer other products like adjustable foldable walkers and MultiSensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged.

FAQs for the comparison of Avience Biomedicals Ltd and Earkart Limited

Which company has a larger market capitalization, Avience Biomedicals Ltd or Earkart Limited?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Earkart Limited is 163 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Earkart Limited?

The stock performance of Avience Biomedicals Ltd and Earkart Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Earkart Limited?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Earkart Limited stock price is INR ₹119.1.

How do dividend payouts of Avience Biomedicals Ltd and Earkart Limited compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Earkart Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.